Placebo News and Research

RSS

Study finds spikes in blood pressure, heart rate, adrenaline after 'dipping' snuff

After snuff use, heart rate increased by about 15 beats per minute (25 percent), systolic blood pressure went up by 12 mmHg (10 percent), and measurements of adrenalin in the bloodstream increased by more than 50 percent.

15 Mar 2005

Growth hormone treatment may reduce serious metabolic conditions

Researchers in Sweden have discovered that growth hormone (GH) treatment may result in the reduction of multiple metabolic disorders associated with abdominal obesity in postmenopausal women.

14 Mar 2005

Protopic and Elidel may cause cancer

Protopic and Elidel, two treatments for eczema approved in 2000 and 2001, have now been found to cause cancer in three different animal species.

13 Mar 2005

Investigational drug may help prevent recurrence of ovarian cancer

A drug that may help prevent recurrence of ovarian cancer by inhibiting development of new blood vessels essential to cancer growth is under study at the Medical College of Georgia.

9 Mar 2005

Blood pressure treatment could cut risk of strokes and heart attacks

A new treatment strategy for hypertension can cut the risk of strokes by around 25 percent and coronary events by around 15 percent according to the preliminary results of a major international trial announced at the American College of Cardiology Late Breaking Clinical Trials II Meeting in Orlando today.

8 Mar 2005

Growth hormone treatment improves symptoms of metabolic disorder in postmenopausal women

Researchers in Sweden have discovered that growth hormone (GH) treatment may result in the reduction of multiple metabolic disorders associated with abdominal obesity in postmenopausal women.

8 Mar 2005

Use of cilostazol, clopidogrel and aspirin results in a significant reduction of thrombotic complications in the prevention of heart attacks

Three drugs, each of which works in a different way, are used in anti-platelet therapy to help prevent restenosis (the reclogging of blood vessels after they have been cleared with percutaneous coronary intervention or PCI) or thrombosis (obstruction of an artery or vein by a blood clot).

7 Mar 2005

Aspirin does not prevent first heart attacks or death from cardiovascular causes in women

The Women's Health Study is the first large clinical trial to study the use of low-dose aspirin to prevent heart attack and stroke in women.

7 Mar 2005

$Vitamin B12 after stroke reduces risk of hip fracture$

Vitamin B12 after stroke reduces risk of hip fracture

Patients who took folic acid and vitamin B12 after their stroke had a reduced risk of hip fracture compared to patients who took placebo, according to an article in the March 2 issue of JAMA.

1 Mar 2005

Researchers can now predict who will benefit from cerclage

Doctors treating pregnant women with threatened preterm birth sometimes sew the cervix closed, a procedure known as cerclage. Despite this traditional intervention, many women still lose the pregnancy.

1 Mar 2005

First study to show cost-effectiveness of pre-diabetes intervention

More than 40 million Americans face a high risk of developing Type 2 diabetes, and it would cost a lot to give all of them intensive help with diet and exercise, or medication, to keep them from developing diabetes.

28 Feb 2005

Finasteride prevents prostate cancer

Recent finding show lives could be saved if men are given the drug Finasteride to prevent prostate cancer. New analysis of data from the Prostate Cancer Prevention Trial in the current issue of CANCER confirms this view. These results represent a milestone in cancer research, showing that prostate cancer could be prevented through drugs.

28 Feb 2005

New compounds for the treatment of HIV/AIDS

Scientists from Tibotec Pharmaceuticals Ltd. presented data on several new compounds for the treatment of HIV/AIDS at the 12th Conference on Retroviruses and Opportunistic Infections (CROI), held February 22-25 in Boston, MA, USA.

27 Feb 2005

Gel provides protection from HIV and herpes

Mount Sinai School of Medicine researchers demonstrated that a gel applied in the vagina provides protection from both the human immunodeficiency virus (HIV) and the herpes simplex Virus. The study, presented at the 12th Conference on Retroviruses and Opportunistic Infections, is the first to show that a gel can retain anti-viral activity within the human vagina.

27 Feb 2005

New imaging technology may serve as objective outcome measures for orthopedic conditions

New imaging technologies are enabling doctors to not only diagnose a variety of orthopaedic and musculoskeletal conditions with more accuracy, but also to determine with unprecedented precision whether clinical recovery from bone, joint or tendon damage is actually complete and not simply a "placebo effect."

27 Feb 2005

Second-generation Antidepressants

A recent article in the prestigious British Medical Journal seems to confirm an increased risk for suicidal behavior among adults taking popular antidepressants. This follows evidence that certain selective serotonin reuptake inhibitors (SSRIs) may have a similar effect among children and adolescents.

27 Feb 2005

Proof that vaccinating children against influenza in the hope of reducing disease spread is inconclusive

Proof that vaccinating children aged 6 to 24 months against influenza in the hope of reducing disease spread is inconclusive. These conclusions are based on a small number of studies based on a large dataset of reasonable quality.

27 Feb 2005

Genzyme begins gene transfer trial for peripheral arterial disease

Genzyme Corporation announced today that the first patient has been treated in a new phase 2 clinical trial examining the safety and effectiveness of locally delivered gene transfer for patients with peripheral arterial disease.

24 Feb 2005

Trial results on the use of recombinant activated factor VII in acute intracerebral haemorrhage

The New England Journal of Medicine (NEJM) today reports positive results from the recently completed clinical trial of recombinant activated factor VII (NovoSeven/rFVIIa) in intracerebral haemorrhage (ICH).

24 Feb 2005

FDA approves Atacand (candesartan cilexetil) for the treatment of heart failure

AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved its angiotensin receptor blocker (ARB) Atacand (candesartan cilexetil) Tablets for the treatment of heart failure (NYHA class II-IV and ejection fraction less than or equal to 40%) to reduce the risk of death from cardiovascular causes and reduce hospitalizations for heart failure.

23 Feb 2005

Placebo News and Research

Study finds spikes in blood pressure, heart rate, adrenaline after 'dipping' snuff

Growth hormone treatment may reduce serious metabolic conditions

Protopic and Elidel may cause cancer

Investigational drug may help prevent recurrence of ovarian cancer

Blood pressure treatment could cut risk of strokes and heart attacks

Growth hormone treatment improves symptoms of metabolic disorder in postmenopausal women

Use of cilostazol, clopidogrel and aspirin results in a significant reduction of thrombotic complications in the prevention of heart attacks

Aspirin does not prevent first heart attacks or death from cardiovascular causes in women

Vitamin B12 after stroke reduces risk of hip fracture

Researchers can now predict who will benefit from cerclage

First study to show cost-effectiveness of pre-diabetes intervention

Finasteride prevents prostate cancer

New compounds for the treatment of HIV/AIDS

Gel provides protection from HIV and herpes

New imaging technology may serve as objective outcome measures for orthopedic conditions

Second-generation Antidepressants

Proof that vaccinating children against influenza in the hope of reducing disease spread is inconclusive

Genzyme begins gene transfer trial for peripheral arterial disease

Trial results on the use of recombinant activated factor VII in acute intracerebral haemorrhage

FDA approves Atacand (candesartan cilexetil) for the treatment of heart failure

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News